Marx J, Welte R, Gasperetti T, Moser P, Joannidis M, Bellmann R
Antimicrob Agents Chemother. 2021; 65(7):e0016921.
PMID: 33875434
PMC: 8218649.
DOI: 10.1128/AAC.00169-21.
Downes K, Fisher B, Zane N
Paediatr Drugs. 2020; 22(2):165-188.
PMID: 31974859
PMC: 7085453.
DOI: 10.1007/s40272-020-00379-2.
Hamamoto H, Horie R, Sekimizu K
Sci Rep. 2019; 9(1):9451.
PMID: 31263251
PMC: 6602958.
DOI: 10.1038/s41598-019-46013-1.
Van Dijck P, Sjollema J, Cammue B, Lagrou K, Berman J, dEnfert C
Microb Cell. 2018; 5(7):300-326.
PMID: 29992128
PMC: 6035839.
DOI: 10.15698/mic2018.07.638.
Zhao Y, Prideaux B, Nagasaki Y, Lee M, Chen P, Blanc L
Antimicrob Agents Chemother. 2017; 61(10).
PMID: 28739797
PMC: 5610477.
DOI: 10.1128/AAC.01009-17.
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
Bellmann R, Smuszkiewicz P
Infection. 2017; 45(6):737-779.
PMID: 28702763
PMC: 5696449.
DOI: 10.1007/s15010-017-1042-z.
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.
Wring S, Randolph R, Park S, Abruzzo G, Chen Q, Flattery A
Antimicrob Agents Chemother. 2017; 61(4).
PMID: 28137806
PMC: 5365645.
DOI: 10.1128/AAC.02068-16.
Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
James K, Laudeman C, Malkar N, Krishnan R, Polowy K
Antimicrob Agents Chemother. 2016; 61(2).
PMID: 27919891
PMC: 5278707.
DOI: 10.1128/AAC.01541-16.
Micafungin treatment and eradication of candiduria among hospitalized patients.
Gabardi S, Martin S, Sura M, Mohammed A, Golan Y
Int Urol Nephrol. 2016; 48(11):1881-1885.
PMID: 27587066
DOI: 10.1007/s11255-016-1410-0.
CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility.
Krishnan B, James K, Polowy K, Bryant B, Vaidya A, Smith S
J Antibiot (Tokyo). 2016; 70(2):130-135.
PMID: 27507631
DOI: 10.1038/ja.2016.89.
Micafungin in the treatment of candiduria: A case series.
Kane L, Muzevich K
Med Mycol Case Rep. 2016; 11:5-8.
PMID: 26937340
PMC: 4752815.
DOI: 10.1016/j.mmcr.2016.01.003.
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin.
Pieralli F, Bazzini C, Vannucchi V, Mancini A, Nozzoli C
Med Mycol Case Rep. 2014; 5:1-3.
PMID: 24936401
PMC: 4052353.
DOI: 10.1016/j.mmcr.2014.04.003.
Tissue penetration of antifungal agents.
Felton T, Troke P, Hope W
Clin Microbiol Rev. 2014; 27(1):68-88.
PMID: 24396137
PMC: 3910906.
DOI: 10.1128/CMR.00046-13.
Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization.
Andes D, Reynolds D, Van Wart S, Lepak A, Kovanda L, Bhavnani S
Antimicrob Agents Chemother. 2013; 57(11):5714-6.
PMID: 23959319
PMC: 3811328.
DOI: 10.1128/AAC.01057-13.
Penetration of micafungin into the burn eschar in patients with severe burns.
Sasaki J, Yamanouchi S, Sato Y, Abe S, Shinozawa Y, Kishino S
Eur J Drug Metab Pharmacokinet. 2013; 39(2):93-7.
PMID: 23771854
DOI: 10.1007/s13318-013-0146-9.
Intraocular penetration of intravenous micafungin in inflamed human eyes.
Mochizuki K, Sawada A, Suemori S, Kawakami H, Niwa Y, Kondo Y
Antimicrob Agents Chemother. 2013; 57(8):4027-30.
PMID: 23689706
PMC: 3719741.
DOI: 10.1128/AAC.02300-12.
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.
Kucharikova S, Sharma N, Spriet I, Maertens J, Van Dijck P, Lagrou K
Antimicrob Agents Chemother. 2013; 57(5):2365-8.
PMID: 23403433
PMC: 3632894.
DOI: 10.1128/AAC.02288-12.
Micafungin concentrations in the plasma and burn eschar of severely burned patients.
Sasaki J, Yamanouchi S, Kudo D, Endo T, Nomura R, Takuma K
Antimicrob Agents Chemother. 2011; 56(2):1113-5.
PMID: 22083486
PMC: 3264244.
DOI: 10.1128/AAC.05381-11.
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.
Glockner A
Eur J Med Res. 2011; 16(4):167-79.
PMID: 21486731
PMC: 3352073.
DOI: 10.1186/2047-783x-16-4-167.
Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography-tandem mass spectrometry.
Farowski F, Cornely O, Vehreschild J, Hartmann P, Bauer T, Steinbach A
Antimicrob Agents Chemother. 2010; 54(5):1815-9.
PMID: 20176892
PMC: 2863689.
DOI: 10.1128/AAC.01276-09.